266 related articles for article (PubMed ID: 25633507)
21. Peripheral T cell and natural killer (NK) T cell lymphomas: a clinicopathological study from a single Australian centre.
McKelvie PA; Thompson PA; Tam CS
Histopathology; 2012 Aug; 61(2):212-23. PubMed ID: 22716228
[TBL] [Abstract][Full Text] [Related]
22. A case of primary cutaneous anaplastic large cell lymphoma with variant anaplastic lymphoma kinase translocation.
Sasaki K; Sugaya M; Fujita H; Takeuchi K; Torii H; Asahina A; Tamaki K
Br J Dermatol; 2004 Jun; 150(6):1202-7. PubMed ID: 15214912
[TBL] [Abstract][Full Text] [Related]
23. A primary systemic ALCL present initially as cutaneous localized skin lesions: report of an unusual case.
ALSayyah A; AlHumidi A
Am J Dermatopathol; 2015 Jan; 37(1):e12-4. PubMed ID: 24752216
[TBL] [Abstract][Full Text] [Related]
24. Skin involvement as the first symptom of rapidly progressive ALK-positive systemic anaplastic large cell lymphoma.
Yu X; Zhang J; Xu K; Li M; Yao Z
Clin Exp Dermatol; 2017 Jul; 42(5):539-542. PubMed ID: 28556361
[TBL] [Abstract][Full Text] [Related]
25. CD8-positive primary cutaneous anaplastic large T-cell lymphoma (PCALCL): case report and review of this unusual variant of PCALCL.
Plaza JA; Ortega P; Lynott J; Mullane M; Kroft S; Olteanu H
Am J Dermatopathol; 2010 Jul; 32(5):489-91. PubMed ID: 20442639
[TBL] [Abstract][Full Text] [Related]
26. Primary cutaneous CD30+ anaplastic large-cell lymphoma with generalized skin involvement and involvement of one peripheral lymph node, successfully treated with low-dose oral etoposide.
Yamane N; Kato N; Nishimura M; Ito M; Yanagi T; Osawa R
Clin Exp Dermatol; 2009 Jul; 34(5):e56-9. PubMed ID: 19438576
[TBL] [Abstract][Full Text] [Related]
27. Chronic reparative changes in medium-sized vessels in a case of primary cutaneous anaplastic large-cell lymphoma with angioinvasive features and cytotoxic phenotype: new histopathological findings in line with indolent clinical behavior.
Macarenco RS; de Oliveira DE
Am J Dermatopathol; 2015 May; 37(5):e53-6. PubMed ID: 25365499
[TBL] [Abstract][Full Text] [Related]
28. [Primary cutaneous anaplastic large cell lymphoma: Report of one case].
Navarrete-Dechent C; Molgó M; Sandoval-Osses M; González S
Rev Med Chil; 2015 Oct; 143(10):1351-5. PubMed ID: 26633281
[TBL] [Abstract][Full Text] [Related]
29. Pediatric case of anaplastic lymphoma kinase-positive anaplastic large cell lymphoma forming a solitary skin tumor on the forearm.
Tokuyama M; Kurashige Y; Ota T; Manabe Y; Yamaoka H; Ikoma N; Fukumura A; Miyashita M; Otsubo K; Morimoto T; Mochizuki H; Nakano N; Nakamura N; Ozawa A; Mabuchi T
J Dermatol; 2017 Apr; 44(4):465-467. PubMed ID: 27864829
[TBL] [Abstract][Full Text] [Related]
30. A Case of ALK+ Anaplastic Large-Cell Lymphoma With Aberrant Myeloperoxidase Expression and Initial Cutaneous Presentation.
Gru AA; Voorhess PJ
Am J Dermatopathol; 2018 Jul; 40(7):519-522. PubMed ID: 29905579
[TBL] [Abstract][Full Text] [Related]
31. [Primary cutaneous anaplastic large cell lymphoma: a clinicopathologic analysis of 8 cases].
Wang TT; Wang L; Tang ZR; Cheng JR; Li W; Li FY; Wang WY; Li GD
Zhonghua Bing Li Xue Za Zhi; 2009 Nov; 38(11):749-53. PubMed ID: 20079014
[TBL] [Abstract][Full Text] [Related]
32. Clusterin is widely expressed in systemic anaplastic large cell lymphoma but fails to differentiate primary from secondary cutaneous anaplastic large cell lymphoma.
Lae ME; Ahmed I; Macon WR
Am J Clin Pathol; 2002 Nov; 118(5):773-9. PubMed ID: 12428799
[TBL] [Abstract][Full Text] [Related]
33. The morphologic spectrum of primary cutaneous anaplastic large T-cell lymphoma: a histopathologic study on 66 biopsy specimens from 47 patients with report of rare variants.
Massone C; El-Shabrawi-Caelen L; Kerl H; Cerroni L
J Cutan Pathol; 2008 Jan; 35(1):46-53. PubMed ID: 18095994
[TBL] [Abstract][Full Text] [Related]
34. Prognostic factors in primary cutaneous anaplastic large cell lymphoma: characterization of clinical subset with worse outcome.
Woo DK; Jones CR; Vanoli-Storz MN; Kohler S; Reddy S; Advani R; Hoppe RT; Kim YH
Arch Dermatol; 2009 Jun; 145(6):667-74. PubMed ID: 19528422
[TBL] [Abstract][Full Text] [Related]
35. Current management of primary cutaneous CD30+ T-cell lymphoproliferative disorders.
Kadin ME
Oncology (Williston Park); 2009 Nov; 23(13):1158-64. PubMed ID: 20043465
[TBL] [Abstract][Full Text] [Related]
36. Cutaneous anaplastic large-cell lymphoma should be evaluated for systemic involvement regardless of ALK-1 status: case reports and review of literature.
Yang S; Khera P; Wahlgren C; Ho J; Jukic D; Geskin L; English JC
Am J Clin Dermatol; 2011 Jun; 12(3):203-9. PubMed ID: 21366363
[TBL] [Abstract][Full Text] [Related]
37. ALK-Negative Primary Cutaneous Anaplastic Large Cell Lymphoma With Systemic Involvement or Systemic ALCL With Cutaneous Lesion. A Diagnostic Dilemma.
Gupta I; Ramteke P; Narwal A; Sharma MC; Bakhshi S; Mallick S
Am J Dermatopathol; 2022 May; 44(5):376-379. PubMed ID: 35234192
[TBL] [Abstract][Full Text] [Related]
38. ALK-positive primary cutaneous T-cell-lymphoma (CTCL) with unusual clinical presentation and aggressive course.
Wehkamp U; Oschlies I; Nagel I; Brasch J; Kneba M; Günther A; Klapper W; Weichenthal M
J Cutan Pathol; 2015 Nov; 42(11):870-7. PubMed ID: 26053561
[TBL] [Abstract][Full Text] [Related]
39. Anaplastic lymphoma kinase expression in a recurrent primary cutaneous anaplastic large cell lymphoma with eventual systemic involvement.
Chan DV; Summers P; Tuttle M; Cooper KD; Cooper B; Koon H; Honda K
J Am Acad Dermatol; 2011 Sep; 65(3):671-673. PubMed ID: 21839333
[No Abstract] [Full Text] [Related]
40. Intravascular ALK-negative anaplastic large cell lymphoma with localized cutaneous involvement and an indolent clinical course: toward recognition of a distinct clinicopathologic entity.
Metcalf RA; Bashey S; Wysong A; Kim J; Kim YH; Gratzinger D
Am J Surg Pathol; 2013 Apr; 37(4):617-23. PubMed ID: 23480896
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]